☰

Hanna Iderberg - Publications

Affiliations: 
2014  
Tree Info Grants Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Iderberg H, Maslava N, Thompson AD, Bubser M, Niswender CM, Hopkins CR, Lindsley CW, Conn PJ, Jones CK, Cenci MA. Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and l-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist. Neuropharmacology. 95: 121-9. PMID 25749357 DOI: 10.1016/J.Neuropharm.2015.02.023  0.574
2015 Iderberg H, McCreary AC, Varney MA, Cenci MA, Newman-Tancredi A. Activity of serotonin 5-HT1A receptor 'biased agonists' in rat models of Parkinson's disease and l-DOPA-induced dyskinesia Neuropharmacology. 93: 52-67. PMID 25645393 DOI: 10.1016/j.neuropharm.2015.01.012  0.475
2015 Iderberg H, McCreary AC, Varney MA, Kleven MS, Koek W, Bardin L, Depoortère R, Cenci MA, Newman-Tancredi A. NLX-112, a novel 5-HT1A receptor agonist for the treatment of l-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat Experimental Neurology. 271: 335-350. DOI: 10.1016/j.expneurol.2015.05.021  0.396
2014 Francardo V, Iderberg H, Lindgren H, Angela Cenci M. Rodent Models of Treatment-Related Complications in Parkinson Disease Movement Disorders: Genetics and Models: Second Edition. 373-386. DOI: 10.1016/B978-0-12-405195-9.00022-6  0.694
2013 Iderberg H, Rylander D, Bimpisidis Z, Cenci MA. Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: effects of combined treatment and possible mechanisms of action. Experimental Neurology. 250: 116-24. PMID 24029003 DOI: 10.1016/J.Expneurol.2013.09.003  0.676
2012 Iderberg H, Francardo V, Pioli EY. Animal models of l-DOPA-induced dyskinesia: An update on the current options Neuroscience. 211: 13-27. PMID 22465440 DOI: 10.1016/J.Neuroscience.2012.03.023  0.731
2011 Lindgren HS, Rylander D, Iderberg H, Andersson M, O'Sullivan SS, Williams DR, Lees AJ, Cenci MA. Putaminal upregulation of FosB/ΔFosB-like immunoreactivity in Parkinson's disease patients with dyskinesia. Journal of Parkinson's Disease. 1: 347-57. PMID 23933656 DOI: 10.3233/Jpd-2011-11068  0.644
2010 Rylander D, Iderberg H, Li Q, Dekundy A, Zhang J, Li H, Baishen R, Danysz W, Bezard E, Cenci MA. A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys. Neurobiology of Disease. 39: 352-61. PMID 20452425 DOI: 10.1016/J.Nbd.2010.05.001  0.722
Show low-probability matches.